LSBCF (LakeShore Biopharma Co) Liabilities-to-Assets : 0.64 (As of Mar. 2025)


What is LakeShore Biopharma Co Liabilities-to-Assets?

LakeShore Biopharma Co LSBCF Liabilities-to-Assets is 0.64 as of Mar. 2025.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. LakeShore Biopharma Co's Total Liabilities for the quarter that ended in Mar. 2025 was $119.72 Mil. LakeShore Biopharma Co's Total Assets for the quarter that ended in Mar. 2025 was $188.66 Mil. Therefore, LakeShore Biopharma Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 was 0.64.

LakeShore Biopharma Co  (OTCPK:LSBCF) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

LakeShore Biopharma Co Liabilities-to-Assets Related Terms

LakeShore Biopharma Co Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Liabilities-to-Assets Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Liabilities-to-Assets
1.44 1.49 0.58 0.61 0.64

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only 0.58 0.65 0.61 0.58 0.64

LSBCF vs ACUT, PPCB, ENSC: Liabilities-to-Assets Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co Liabilities-to-Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Liabilities-to-Assets falls into.


LakeShore Biopharma Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

LakeShore Biopharma Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2025 is calculated as:

Liabilities-to-Assets (A: Mar. 2025 )=Total Liabilities/Total Assets
=119.723/188.661
=0.63

LakeShore Biopharma Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 is calculated as

Liabilities-to-Assets (Q: Mar. 2025 )=Total Liabilities/Total Assets
=119.723/188.661
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 0.64 mean?
LakeShore Biopharma Co (LSBCF) has a Liabilities-to-Assets of 0.64 as of Mar. 2025. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Liabilities-to-Assets too high?
LakeShore Biopharma Co's current Liabilities-to-Assets is 0.64.
How does LakeShore Biopharma Co's Liabilities-to-Assets compare to ACUT and PPCB?
LakeShore Biopharma Co's Liabilities-to-Assets of 0.64 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Biotechnology company?
A good Liabilities-to-Assets depends on the Biotechnology industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Liabilities-to-Assets is 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Liabilities-to-Assets of 0.64. The current Liabilities-to-Assets is 0.64. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Liabilities-to-Assets is 0.64 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.